Historical record - last NADAC effective date: 6/17/2015
Product Information
B-COMPLEX 100 INJECTION is a generic product labeled by Mylan Institutional LLC, priced at $6.1199 per ML under NDC 67457014630. Its NADAC has been published 134 times since Nov 28, 2013.
B-COMPLEX 100 INJECTION
thiamine hydrochloride, riboflavin 5 phosphate sodium, dexpanthenol and niacinamideStrength
2; 100; 2; 2; 100 mg/mL; mg/mL; mg/mL; mg/mL; mg/mL
Manufacturer
Mylan Institutional LLCNDC
67457014630
Classification
Generic
Dosage Form
INJECTION
Route
INTRAVENOUS
Effective Date
6/17/2015
Active Ingredients
DEXPANTHENOL; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDEApproval Type
Unapproved
On Market Since
5/10/2013
Pharmacological Classes
Price Statistics
The NADAC for B-COMPLEX 100 INJECTION has been published 134 times since Nov 28, 2013, and over the history we have for it it has risen 476.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.1199 per ML |
|---|---|
| All-time high | $6.1199 (Jun 15, 2016) |
| All-time low | $1.0224 (Dec 18, 2013) |
| Median price | $1.3999 |
| Average price | $3.1983 |
| Largest weekly change | +337.2% (Jun 17, 2015) |
| Weeks tracked | 134 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+476.2%
Last surveyed Jun 15, 2016 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the thiamine hydrochloride, riboflavin 5 phosphate sodium, dexpanthenol and niacinamide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Institutional LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
thiamine hydrochloride, riboflavin 5 phosphate sodium, dexpanthenol and niacinamide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Vitamin B6 Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of B-COMPLEX 100 INJECTION?
The current National Average Drug Acquisition Cost (NADAC) for B-COMPLEX 100 INJECTION, manufactured by Mylan Institutional LLC, is $6.1199 per ML (NDC 67457014630), effective Jun 15, 2016.
How has the price of B-COMPLEX 100 INJECTION changed over time?
Over the history we have for it, the NADAC for B-COMPLEX 100 INJECTION has risen 476.2%. It has been tracked across 134 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for B-COMPLEX 100 INJECTION?
Since Nov 28, 2013, the NADAC for B-COMPLEX 100 INJECTION has ranged from a low of $1.0224 (Dec 18, 2013) to a high of $6.1199 (Jun 15, 2016), with a median of $1.3999 per ML.
Are there cheaper alternatives to B-COMPLEX 100 INJECTION?
No other NADAC-published product currently shares the active ingredient and strength of B-COMPLEX 100 INJECTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures B-COMPLEX 100 INJECTION?
B-COMPLEX 100 INJECTION (NDC 67457014630) is labeled by Mylan Institutional LLC, and CMS classifies it as a generic product.